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Background: Adenosine (Ado) is released in response to tissue injury and promotes hyperemia and inflammation. The proinflammatory effects of 
Ado, which are mediated by the A2B Ado receptor (AdoR), cause further tissue damage. We hypothesized that selective blockade of the A2B AdoR 
during acute myocardial infarction would reduce cardiac remodeling.
Methods: Male ICR mice underwent coronary artery ligation or sham surgery (N=10-12 per group). A selective A2B AdoR antagonist, GS-6201 
(4 mg/kg) was given i.p. BID starting immediately after surgery and continued for 14 days. Transthoracic echocardiography was performed prior 
to surgery and after 7, 14 and 28 days. A subgroup of mice was killed 72 hours after surgery and the activity of caspase-1, a key proinflammatory 
mediator, was measured in the cardiac tissue.
Results: All sham operated mice were alive at 4 weeks, whereas 42% of vehicle-treated mice and 25% of GS-6201-treated mice died during the 
4 weeks after surgery. When compared with vehicle, treatment with GS-6201 significantly reduced caspase-1 activity in the heart tissue 72 hours 
after AMI, and significantly limited the increase in LV end-diastolic diameter, the decrease in LV ejection fraction and the increase in the myocardial 
performance index, reflective of worse performance at 7 days and 28 days after AMI (Figure).
Conclusions: Selective blockade of A2B AdoR with GS-6201 reduces caspase-1 activity in the heart and leads to a more favorable cardiac 
remodeling after AMI in the mouse.
 
